Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy

Swiss Medical Weekly

Volumn 141, Issue NOVEMBER, 2011, Pages

  Spichiger, Elisabeth ^a,d   Müller Fröhlich, Christa ^a   Denhaerynck, Kris ^a   Stoll, Hansruedi ^b   Hantikainen, Virpi ^c   Dodd, Marylin ^e  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c FHO Fachhochschule Ostschweiz   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer chemotherapy; Fatigue; Longitudinal study; Neoplasms; Outpatients; Prevalence study; Signs and symptoms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; COLD; COLORECTAL CANCER; DIARRHEA; DROWSINESS; DRY NOSE; EYE DISEASE; FATIGUE; HAIR LOSS; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MUSCLE CRAMP; PAIN; PARESTHESIA; PREVALENCE; SCORING SYSTEM; SKIN MANIFESTATION; SLEEP DISORDER; SYMPTOM; TERTIARY HEALTH CARE; XEROSTOMIA; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED; NEOPLASM; OUTPATIENT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SWITZERLAND;

ADULT; AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OUTPATIENTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SWITZERLAND; YOUNG ADULT;

EID: 82655169409     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13303     Document Type: Article

References (63)

1. Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, et al. National Institutes of Health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003;95(15):1110-17.
2. Miaskowski C, Aouizerat BE, Dodd M, Cooper B. Conceptual issues on symptom clusters research and their implications for quality-of-life assessments in patients with cancer. J Natl Cancer Inst Monogr. 2007;37:39-46.
3. Hoffman AJ, Given BA, von Eye A, Gift AG, Given CW. Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum. 2007;34:785-92.
4. Akin S, Can G, Aydiner A, Ozdilli K, Durna Z. Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 2010;14:400-9.
5. Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM, Aranda SK. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust. 2009;7:S99-S104.
6. Yamagishi Y, Morita T, Miyashita M, Kimura R. Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain Symptom Manage. 2009;37:823-30.
7. Chou F, Dodd M, Abrams D, Padilla G. Symptoms, self care, and quality of life of Chinese American patients with cancer. Oncol Nurs Forum. 2007;34:1162-7.
8. Gwede CK, Small BJ, Munster PN, Andrykowski MA, Jacobsen PB. Exploring the differential experience of breat cancer treatment-related symptoms: A cluster analytic approach. Support Care Cancer. 2008;16:925-33.
9. Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage. 2000;20:104-12.
10. Berger AM, Abernethy AP, Atkinson A, Barsewick AM, Breitbart WS, Cella D, et al. Cancer-related fatigue: Practice guidelines in oncology [Internet]. National Comprehensive Cancer Network; 2009 [cited 2009 Jun 6]. Available at: http://www.nccn.org/professionals/physician-gls/PDF/fatigue.pdf.
11. Vainio A, Auvinen A, Ahmedzai S, Benton TF, Walsh D, Higginson I, et al. Prevalence of symptoms among patients with advanced cancer: An international collaborative study. J Pain Symptom Manage. 1996;12(1):3-10. (Pubitemid 26187518)
12. Reuter K. Fatigue und/oder Depression? Ein Beitrag zur Konstruktvalidierung und diagnostischen Unterscheidung bei Patienten mit Tumorerkrankungen. Freiburg i. Br.: Albert-Ludwigs-Universität; 2002.
13. Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, et al. The European cancer anaemia survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40:2293-306. (Pubitemid 39348881)
14. National Cancer Institute. Oral complications of chemotherapy and head/neck radiation [Internet]. National Cancer Institute; 2009 [cited 2009 Jul 31]. Available at: http://www.cancer.gov/cancertopics/pdq/supportivecare/ oralcomplications/HealthProfessional.
15. U. S. Department of Health and Human Services, National Institute of Health, National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 4.0 [Internet]. 2009 [cited 2009 Jul31]. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-application/docs/ctcae4. pdf.
16. Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol. 2000;10:175-90. (Pubitemid 30452634)
17. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional national survey in the U. S. Support Care Cancer. 2008;16:791-801.
18. Chang VT, Hwang SS, Feuerman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: A role for symptom assessment. Cancer. 2000;88:1175-83. (Pubitemid 30127680)
19. Lo RSK, Ding A, Chung TK, Woo J. Prospective study of symptom control in 133 cases of palliative care inpatients in Shatin hospital. Palliat Med. 1999;13:335-40. (Pubitemid 29378211)
20. Potter J, Hami F, Bryan T, Quigley C. Symptoms in 400 patients referred to palliative care services: Prevalence and patterns. Palliat Med. 2003;17:310-4. (Pubitemid 36748433)
21. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183-9. (Pubitemid 24253426)
22. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A:1326-36. (Pubitemid 24322071)
23. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-AN) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl 2):13-9. (Pubitemid 27319140)
24. Cella D, Eton DT, Fairclough DL, Bonomi P, Heyes AE, Silberman C, et al. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) study 5592. J Clin Epidemiol. 2002;55:285-95. (Pubitemid 34195525)
25. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63-74. (Pubitemid 27147321)
26. Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gangeri L, et al. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res. 1996;5:309-20. (Pubitemid 26228464)
27. Herrmann C, Buss U, Snaith RP. HADS-D Hospital Anxiety and Depression Scale - deutsche Version. Ein Fragebogen zur Erfassung von Angst und Depression in der somatischen Medizin. Testdokumentation und Handanweisung. Bern, Huber, 1995.
28. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Scand. 1983;67:361-70. (Pubitemid 13098606)
29. Reuter K, Härter M. Screening for mental disorders in cancer patients - discriminant validity of HADS and GHQ-12 assessed by standardized clinical interviews. Int J Methods Psychiatr Res. 2001;10:86-96.
30. Eastern Cooperative Oncology Group: ECOG performance status [Internet]. 2000 [cited 2005 Jan 10]. Available at: http://www.ecog.org/general/perf-stat. html.
31. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55. (Pubitemid 13149996)
32. Hann DM, Jacobsen PB, Martin SC, Kronish LE, Azzarello LM, Fields KK. Quality of life following bone marrow transplantation for breast cancer: A comparative study. Bone Marrow Transplantation. 1997;19:257-64. (Pubitemid 27077483)
33. Bladgen SP, Charman SC, Sharples LD, Magee LRA, Gilligan D. Performance status score: Do patients and their oncologists agree? Br J Cancer. 2003;89:1022-7. (Pubitemid 37239205)
34. Corless IB, Nicholas PK, Nokes KM. Issues in cross-cultural quality-of-life research. J Nurs Sch. 2001;33:15-20. (Pubitemid 33613169)
35. Flaherty JA. Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis. 1988;176:257-63.
36. Jones PS, Lee JW, Phillips LR, Zhang XE, Jaceldo KB. An adaptation of Brislin's translation model for cross-cultural research. Nurs Res. 2001;50:300-4. (Pubitemid 33603821)
37. Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997;14:328-31. (Pubitemid 27518561)
38. Cooley ME, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology. 2003;12:694-708. (Pubitemid 37236022)
39. Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol. 1995;22(2 Suppl 3):67-72.
40. Feyer P, Kleeberg UR, Steingraber M, Gunther W, Behrens M. Frequency of side effects in outpatient cancer care and their influence on patient satisfaction - a prospective survey using the PASQOC questionnaire. Support Care Cancer. 2008;16:567-75.
41. Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31:203-12.
42. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247-57. (Pubitemid 32763182)
43. Schuit KW, Sleijfer DT, Meijler WJ, Otter R, Schakenraad J, van den Bergh FC, et al. Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage. 1998;16:290-7. (Pubitemid 28545909)
44. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J Pain Symptom Manage. 2003;25:420-9. (Pubitemid 36506670)
45. Yan H, Sellick K. Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer. Cancer Nurs. 2004;27:389-99. (Pubitemid 39346530)
46. Breitbart W, Chochinov HM, Passik S. Psychiatric aspects of palliative care. In Doyle D, Hanks GWC, MacDonald N, editors. Oxford textbook of palliative medicine. Oxford: Oxford University Press; 1998. p 933-54.
47. Cella D, Lai JS, Chang CH, Peterman AH, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528-38. (Pubitemid 34081385)
48. Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14:201-9. (Pubitemid 43247923)
49. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24:547-61. (Pubitemid 36120443)
50. Reddy S, Bruera E, Pace E, Zhang K, Reyes-Gibby CC. Clinically important improvement in the intensity of fatigue in patients with advanced cancer. J Palliat Med. 2007;10:1068-75. (Pubitemid 350073556)
51. Servaes P, Verhagen C, Bleijenberg G. Review: Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer. 2002;38:27-43. (Pubitemid 34031823)
52. Hartvig P, Aulin J, Hugerth M, Wallenberg S, Wagenius G. Fatigue in cancer patients treated with cytotoxic drugs. J Oncol Pharm Practice. 2006;12:155-64. (Pubitemid 44696443)
53. Karakoc T, Yurtsever S. Relationship between social support and fatigue in geriatric patients receiving outpatient chemotherapy. Eur J Oncol Nurs. 2010;14:61-7.
54. Respini D, Jacobsen PB, Thors C, Tralongo P, Balducci L. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol. 2003;47:273-9. (Pubitemid 37072118)
55. Lee YH, Tsai YF, Lai YH, Tsai CM. Fatigue experience and coping strategies in Taiwanese lung cancer patients receiving chemotherapy. J Clin Nurs. 2008;17:876-83.
56. Donovan KA, Jacobsen PB, Andrykowski MA, Winters EM, Balducci L, Malik U, et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage. 2004;28:373-80. (Pubitemid 39313166)
57. Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 1998;25:51-62.
58. Siefert ML. Fatigue, pain, and functional status during outpatient chemotherapy. Oncol Nurs Forum. 2010;37:E114-23.
59. Can G, Durna Z, Aydiner A. Assessment of fatigue in and care needs of Turkish women with breast cancer. Cancer Nurs. 2004;27:153-61. (Pubitemid 38420163)
60. Cella D, Kallich J, McDermott A. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Ann Oncol. 2004;15:979-86. (Pubitemid 39004357)
61. Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, et al. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004;28:7-18. (Pubitemid 38829668)
62. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: A systematic review. J Pain Symptom Manage. 2007;34:94-104. (Pubitemid 46970881)
63. Berger A. Treating fatigue in cancer patients. Oncologist. 2003;8(Suppl 1):10-4. (Pubitemid 36331742)